SitesBLAST
Comparing WP_017547620.1 NCBI__GCF_000330705.1:WP_017547620.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
3dc2A Crystal structure of serine bound d-3-phosphoglycerate dehydrogenase from mycobacterium tuberculosis (see paper)
38% identity, 99% coverage: 6:530/530 of query aligns to 4:526/526 of 3dc2A
- active site: N96 (= N100), R230 (= R234), D254 (= D258), E259 (= E263), H277 (= H281)
- binding serine: Y458 (≠ H462), D460 (= D464), R461 (= R465), P462 (= P466), G463 (= G467), A464 (≠ I468), L465 (≠ I469), L484 (= L488)
3ddnB Crystal structure of hydroxypyruvic acid phosphate bound d-3- phosphoglycerate dehydrogenase in mycobacterium tuberculosis (see paper)
38% identity, 99% coverage: 6:530/530 of query aligns to 5:525/525 of 3ddnB
O43175 D-3-phosphoglycerate dehydrogenase; 3-PGDH; 2-oxoglutarate reductase; Malate dehydrogenase; EC 1.1.1.95; EC 1.1.1.399; EC 1.1.1.37 from Homo sapiens (Human) (see 3 papers)
38% identity, 78% coverage: 9:420/530 of query aligns to 15:423/533 of O43175
- T78 (≠ V76) binding NAD(+)
- R135 (= R133) to W: in PHGDHD; results in a 2-fold decrease in enzyme activity with 3-phosphohydroxypyruvate, but no change in substrate affinity; dbSNP:rs267606949
- RI 155:156 (≠ KI 153:154) binding NAD(+)
- D175 (= D173) binding NAD(+)
- T207 (= T205) binding NAD(+)
- CAR 234:236 (≠ VAR 232:234) binding NAD(+)
- D260 (= D258) binding NAD(+)
- V261 (= V259) to M: in PHGDHD; results in a four-fold decrease in substrate affinity and a slight increase in maximal enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs267606947
- HLGA 283:286 (= HLGA 281:284) binding NAD(+)
- A373 (≠ S371) to T: in PHGDHD; results in almost undetectable enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs201553627
- G377 (≠ S375) to S: in PHGDHD; results in a 2-fold decrease in enzyme activity with 3-phosphohydroxypyruvate, but no change in substrate affinity; dbSNP:rs267606948
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 2 modified: N-acetylalanine
- 425 V → M: in PHGDHD; results in almost undetectable enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs121907988
- 490 V → M: in PHGDHD; results in almost undetectable enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs121907987
6plfA Crystal structure of human phgdh complexed with compound 1 (see paper)
45% identity, 56% coverage: 9:306/530 of query aligns to 11:304/305 of 6plfA
6plgA Crystal structure of human phgdh complexed with compound 15 (see paper)
45% identity, 56% coverage: 9:306/530 of query aligns to 10:303/303 of 6plgA
7dkmA Phgdh covalently linked to oridonin (see paper)
45% identity, 56% coverage: 9:306/530 of query aligns to 11:304/306 of 7dkmA
- binding nicotinamide-adenine-dinucleotide: T74 (≠ V76), A102 (= A104), G148 (= G150), R151 (≠ K153), I152 (= I154), Y170 (≠ F172), D171 (= D173), P172 (= P174), I173 (≠ Y175), H202 (= H204), T203 (= T205), P204 (= P206), T209 (= T211), C230 (≠ V232), A231 (= A233), R232 (= R234), H279 (= H281), G281 (= G283)
- binding (1beta,6beta,7beta,8alpha,9beta,10alpha,13alpha,14R,16beta)-1,6,7,14-tetrahydroxy-7,20-epoxykauran-15-one: C14 (≠ V12), K17 (≠ E19), I18 (≠ L20), E293 (≠ I295)
6rj2A Crystal structure of phgdh in complex with compound 40 (see paper)
45% identity, 56% coverage: 9:305/530 of query aligns to 7:299/299 of 6rj2A
- binding ~{N}-[(1~{R})-1-[4-(ethanoylsulfamoyl)phenyl]ethyl]-2-methyl-5-phenyl-pyrazole-3-carboxamide: G146 (= G152), I148 (= I154), Y166 (≠ F172), D167 (= D173), P168 (= P174), I169 (≠ Y175), I170 (≠ L176), H198 (= H204), T199 (= T205), L208 (≠ I214), R228 (= R234)
7ewhA Crystal structure of human phgdh in complex with homoharringtonine (see paper)
45% identity, 56% coverage: 9:305/530 of query aligns to 10:302/302 of 7ewhA
- binding (3beta)-O~3~-[(2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine: L146 (≠ I149), G147 (= G150), L148 (≠ V151), G149 (= G152), R150 (≠ K153), I151 (= I154), G152 (= G155), D170 (= D173), H201 (= H204), T202 (= T205), P203 (= P206)
6rihA Crystal structure of phgdh in complex with compound 9 (see paper)
45% identity, 56% coverage: 9:305/530 of query aligns to 10:302/302 of 6rihA
6rj5A Crystal structure of phgdh in complex with compound 39 (see paper)
46% identity, 56% coverage: 9:304/530 of query aligns to 10:301/301 of 6rj5A
6cwaA Crystal structure phgdh in complex with nadh and 3-phosphoglycerate at 1.77 a resolution (see paper)
46% identity, 56% coverage: 9:303/530 of query aligns to 9:299/299 of 6cwaA
- binding 1,4-dihydronicotinamide adenine dinucleotide: N96 (= N100), A100 (= A104), R149 (≠ K153), I150 (= I154), Y168 (≠ F172), D169 (= D173), P170 (= P174), I171 (≠ Y175), H200 (= H204), T201 (= T205), P202 (= P206), T207 (= T211), C228 (≠ V232), A229 (= A233), R230 (= R234), H277 (= H281), G279 (= G283)
6rj3A Crystal structure of phgdh in complex with compound 15 (see paper)
47% identity, 54% coverage: 9:293/530 of query aligns to 9:289/297 of 6rj3A
6plfB Crystal structure of human phgdh complexed with compound 1 (see paper)
46% identity, 50% coverage: 39:304/530 of query aligns to 31:292/292 of 6plfB
- binding 4-{(1S)-1-[(5-chloro-6-{[(5S)-2-oxo-1,3-oxazolidin-5-yl]methoxy}-1H-indole-2-carbonyl)amino]-2-hydroxyethyl}benzoic acid: R141 (≠ K153), Y160 (≠ F172), D161 (= D173), P162 (= P174), I164 (≠ L176), L179 (≠ V191), T193 (= T205), P194 (= P206), S198 (≠ Q210), L202 (≠ I214)
7cvpA The crystal structure of human phgdh from biortus.
47% identity, 42% coverage: 82:303/530 of query aligns to 33:254/254 of 7cvpA